Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | MAOA | P21397 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | DAPK1 | P53355 | 2/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.44 |
| ▸ | BCL2 | P10415 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3686051 | 0.86 | HPGD (0.52) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL27705003 | 0.83 | KDM4E (0.63) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL7063105 | 0.81 | ALDH1A1 (0.50) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL16914158 | 0.81 | ALDH1A1 (0.61) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL7426449 | 0.80 | BCAT2 (0.48) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL6389889 | 0.77 | ALDH1A1 (0.55) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL30026063 | 0.76 | HPGD (0.52) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL41435 | 0.76 | KEAP1 (0.64) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL1151769 | 0.76 | HPGD (0.52) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL975811 | 0.75 | KDM4E (0.68) | KDM4EMAPTALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104886-A1 | METHOD FOR EXTRACTING LOW-MOLECULAR WEIGHT COLLAGEN USING POLLACK SKIN, LOW-MOLECULAR WEIGHT COLLAGEN, AND COSMETIC COMPOSITION COMPRISING SAME WITH SKIN REGENERATION EFFICACY | 유엔케이코리아 주식회사 | 2026-05-21 | — | — | WO | disclosed |
| US-12350352-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2025-07-08 | — | — | US | disclosed |
| EP-3342395-B1 | COMPOSITION FOR HAIR SURFACE MODIFICATION | LG HOUSEHOLD & HEALTH CARE LTD (KR) | 2024-08-07 | — | — | EP | disclosed |
| EP-4406617-A2 | COMPOSITION FOR SURFACE MODIFICATION | LG Household & Health Care Ltd. (KR) | 2024-07-31 | — | — | EP | disclosed |
| US-11612552-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. | 2023-03-28 | — | — | US | disclosed |
| US-20230088314-A1 | Composition For Surface Modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2023-03-23 | — | — | US | disclosed |
| WO-2022114681-A1 | CLEANSER COMPOSITION WITH ENHANCED ACTIVE SUBSTANCE DELIVERY | 주식회사 엘지생활건강 | 2022-06-02 | — | — | WO | disclosed |
| CN-107920973-B | Surface modification composition | 株式会社LG生活健康 | 2021-05-07 | — | — | CN | disclosed |
| US-20200345599-A1 | Composition For Surface Modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2020-11-05 | — | — | US | disclosed |
| US-10799436-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2020-10-13 | — | — | US | disclosed |
| EP-3342395-A2 | COMPOSITION FOR SURFACE MODIFICATION | LG Household & Health Care Ltd. (KR) | 2018-07-04 | — | — | EP | disclosed |
| CN-107920973-A | Surface composition for modifying | 株式会社LG生活健康 | 2018-04-17 | — | — | CN | disclosed |
| EP-2617408-A2 | Two phase face cleaner with high ocular and mucous membrane compatibility | Henkel AG&Co. KGAA (DE) | 2013-07-24 | — | — | EP | disclosed |
| US-8067351-B2 | Composition with a color marker | COLGATE-PALMOLIVE COMPANY (US) | 2011-11-29 | — | — | US | disclosed |
| EP-2346476-A1 | COMPOSITION WITH A COLOR MARKER | Colgate-Palmolive Company (US) | 2011-07-27 | — | — | EP | disclosed |
| EP-2346477-A1 | COMPOSITION WITH A COLOR TO INDICATE COVERAGE | Colgate-Palmolive Company (US) | 2011-07-27 | — | — | EP | disclosed |
| US-20110021397-A1 | Composition With A Color Marker | COLGATE-PALMOLIVE COMPANY | 2011-01-27 | — | — | US | disclosed |
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | CIBA CORPORATION (US) | 2010-06-10 | — | — | US | disclosed |
| WO-2010056232-A1 | COMPOSITION WITH A COLOR MARKER | COLGATE PALMOLIVE COMPANY (US) | 2010-05-20 | — | — | WO | disclosed |
| WO-2010056233-A1 | COMPOSITION WITH A COLOR TO INDICATE COVERAGE | COLGATE-PALMOLIVE COMPANY (US) | 2010-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | MAOA, MAOB, ACMSD | KDM4E 545/4885MAPT 292/4885ALDH1A1 464/4885 |
| US-12350352-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | KDM4E 214/4885MAPT 2875/4885ALDH1A1 1329/4885 |
| US-20230088314-A1 | Composition For Surface Modification | CUTA, PTMS, DNMT1 | KDM4E 214/4885MAPT 2875/4885ALDH1A1 1329/4885 |
| US-11612552-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | KDM4E 214/4885MAPT 2875/4885ALDH1A1 1329/4885 |
| US-10799436-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | KDM4E 214/4885MAPT 2875/4885ALDH1A1 1329/4885 |
| US-20200345599-A1 | Composition For Surface Modification | CUTA, PTMS, DNMT1 | KDM4E 214/4885MAPT 2875/4885ALDH1A1 1329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.